specific immunity
Recently Published Documents


TOTAL DOCUMENTS

978
(FIVE YEARS 181)

H-INDEX

63
(FIVE YEARS 9)

2022 ◽  
Vol 12 ◽  
Author(s):  
Agnieszka Czerwińska-Błaszczyk ◽  
Edyta Pawlak ◽  
Tomasz Pawłowski

Toll-like receptors (TLR) are a group of protein belonging to the family of Pattern Recognition Receptors (PRR) which have the ability to distinguish between an organism's own antigens and foreign ones and to induce immunological response. TLR play a significant part in non-specific immunity but at the same time they are also a vital element linking non-specific response to the specific one. A growing number of data seems to indicate that the non-specific immunity mechanisms affect the development and sustenance of alcohol addiction. Alcohol damages the organism's cells not only directly but also through an increase inintestinal permeability which induces innate immune response of peripheral blood cells. The signaling pathway of Toll-like receptors located on the surface of brain immune cells intensifies the inflammatory reaction and, through modifying gene expression of proinflammatory factors, unnaturally supports it. This overly protracted “sterile inflammatory reaction” positively correlates with alcohol craving affecting also the functioning of the reward system structures and increasing the risk of relapse of alcoholism. Recurrent alcoholic binges sensitize the microglia and cause an escalation in inflammatory reaction which also leads to neurodegeneration. The induction of innate immunity signaling pathways exposes clinical symptoms of alcohol addiction such as increased impulsivity, loss of behavioral control, depressive-anxiety symptoms and cognitive dysfunctions. Traditional methods of treating alcohol addiction have tended to focus predominantly on reducing symptoms which—given the frequency of relapses—seems insufficient. The aim of the present paper is to discuss the role of toll-like receptors as elements of the immunity system which, together with the nervous system, plays a crucial part in the pathogenesis of alcohol addiction. We also wish to present pharmacotherapeutic perspectives targeted at the neuroimmunological mechanisms of alcohol addiction.


2022 ◽  
Vol 98 (6) ◽  
pp. 648-656
Author(s):  
G. M. Ignatyev ◽  
I. A. Leneva ◽  
A. V. Atrasheuskaya ◽  
L. I. Kozlovskaya ◽  
N. P. Kartashova ◽  
...  

Introduction. In clinical practice, the differential diagnosis of COVID-19 can be challenging during the flu season, entailing serious consequences such as delays in appropriate control measures against the SARS-CoV-2 pandemic. Another problem is posed by co-infection of SARS-CoV-2 and influenza virus (IV), which significantly contributes to the severity of the COVID-19 disease. This study was aimed to explore the cross-impact of co-administration of Russian influenza and COVID-19 vaccines on development of specific immunity in laboratory animals.Materials and methods. The study was conducted on BALB/c mice. The animals were inoculated intramuscularly with the vaccine for COVID-19 prevention (CoviVac) and the vaccine for influenza prevention (Flu-M). The sera from the immunized animals were examined separately. Three IV strains were used in the hemagglutination inhibition assay. Antibodies (Abs) against SARS-CoV-2 were detected by an enzyme-linked immunosorbent assay (ELISA). The neutralization test was performed to detect virus neutralizing antibodies against SARS-CoV-2 and IV.Results. Relatively high titers of specific Abs were found in the groups of animals inoculated with one vaccine and with two vaccines concurrently. In the groups of animals inoculated with CoviVac and with two vaccines concurrently, both in the ELISA test and in the neutralization test, the average titers of specific Abs against SARSCoV- 2 did not demonstrate any statistical difference. The group of animals inoculated concurrently with two vaccines demonstrated statistically higher titers of Abs against IV after the second immunization compared to the group of animals inoculated with Flu-M.Discussion. The study has shown that post-vaccination immunity both to IV and to SARS-CoV-2 develops after co-vaccination with two vaccines. The observed enhanced post-vaccination immune response to IV in the coimmunized laboratory animals needs further research.Conclusion. The performed studies suggest the possibility of co-administration of two vaccines to prevent influenza and COVID-19.


2022 ◽  
Vol 13 (1) ◽  
Author(s):  
Nina Koerber ◽  
Alina Priller ◽  
Sarah Yazici ◽  
Tanja Bauer ◽  
Cho-Chin Cheng ◽  
...  

AbstractAnti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we characterize the dynamics of anti-viral immunity during long-term follow-up and after BNT162b2 mRNA-vaccination in convalescents after asymptomatic or mild SARS-CoV-2 infection. Virus-specific and virus-neutralizing antibody titers rapidly declined in convalescents over 9 months after infection, whereas virus-specific cytokine-producing polyfunctional T cells persisted, among which IL-2-producing T cells correlated with virus-neutralizing antibody titers. Among convalescents, 5% of individuals failed to mount long-lasting immunity after infection and showed a delayed response to vaccination compared to 1% of naïve vaccinees, but successfully responded to prime/boost vaccination. During the follow-up period, 8% of convalescents showed a selective increase in virus-neutralizing antibody titers without accompanying increased frequencies of circulating SARS-CoV-2-specific T cells. The same convalescents, however, responded to vaccination with simultaneous increase in antibody and T cell immunity revealing the strength of mRNA-vaccination to increase virus-specific immunity in convalescents.


2022 ◽  
Vol 1 (1) ◽  
pp. 238-243
Author(s):  
Ernawati Ernawati ◽  
Baik Heni Rispawati ◽  
Dewi Nursukma Purqoty ◽  
Fitri Romadonika ◽  
Raudatul Jannah

 ABSTRAK Vaksin Covid-19 merupakan bentuk pencegahan yang berfungsi mendorong pembentukan kekebalan tubuh sfesifik pada penyakit covid 19 agar terhindar dari tertular atau memungkinkan sakit berat. Sekitar 7,6 persen masyarakat yang menolak untuk divaksinasi dan 26,6 persen masyarakat belum memutuskan dan masih kebingungan untuk melakukan vaksinasi, sehingga diperlukan adanya edukasi kesehatan tentang vaksin Covid-19. Tujuan setelah dilakukan pendidikan kesehatan, diharapkan dapat meningkatkan pengetahuan dan pemahaman masyarakat tentang penyakit Covid-19, cara pencegahannya dan pemahaman tentang program vaksinasi Covid-19 di dusun tempit desa bajur lombok barat.. Adapun kegiatan yang dilakukan berupa kegiatan edukasi menggunakan LCD untuk penyampaian materi dan peserta diberikan leaflet. Terdapat peningkatan pengetahuan dan pemahaman masyarakat tentang program vaksinasi covid-19 dari 60% menjadi 90%. Kata Kunci: Covid-19, Vaksinasi, Penyuluhan  ABSTRACT A Covid-19 vaccine is a form of prevention that functions to encourage the formation of specific immunity for COVID-19 disease to avoid contracting or allowing serious illness. Around 7.6 percent of the people refuse to be vaccinated and 26.6 percent of the people have not decided and are still confused about getting vaccinated, so health education about the Covid-19 vaccine is needed. The goal after health education is carried out is that it is expected to increase public knowledge and understanding of the Covid-19 disease, how to prevent it, and understanding of the Covid-19 vaccination program in the tempest hamlet, Bajur Village, West Lombok. The activities carried out are in the form of educational activities using LCD to deliver material and participants were given leaflets. There is an increase in public knowledge and understanding of the covid-19 vaccination program from 60% to 90%. Keywords: Covid-19, vaccination, Counseling


2021 ◽  
Vol 17 (12) ◽  
pp. e1010085
Author(s):  
Ryuta Uraki ◽  
Masaki Imai ◽  
Mutsumi Ito ◽  
Hiroaki Shime ◽  
Mizuyu Odanaka ◽  
...  

Regulatory T (Treg) cells, which constitute about 5–10% of CD4+T cells expressing Foxp3 transcription factor and CD25(IL-2 receptor α chain), are key regulators in controlling immunological self-tolerance and various immune responses. However, how Treg cells control antigen-specific immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. In this study, we examined the effect of transient breakdown of the immunological tolerance induced by Treg-cell depletion on adaptive immune responses against administered SARS-CoV-2 antigen, spike protein 1 (S1). Notably, without the use of adjuvants, transient Treg-cell depletion in mice induced anti-S1 antibodies that neutralized authentic SARS-CoV-2, follicular helper T cell formation and S1-binding germinal center B cell responses, but prevented the onset of developing autoimmune diseases. To further clarify the mechanisms, we investigated maturation of dendritic cells (DCs), which is essential to initiate antigen-specific immunity. We found that the transient Treg-cell depletion resulted in maturation of both migratory and resident DCs in draining lymph nodes that captured S1-antigen. Moreover, we observed S1-specific CD4+ T cells and CD8+ T cells with interferon-γ production. Thus, captured S1 was successfully presented by DCs, including cross-presentation to CD8+ T cells. These data indicate that transient Treg-cell depletion in the absence of adjuvants induces maturation of antigen-presenting DCs and succeeds in generating antigen-specific humoral and cellular immunity against emerging SARS-CoV-2 antigens. Finally, we showed that SARS-CoV-2 antigen-specific immune responses induced by transient Treg-cell depletion in the absence of adjuvants were compatible with those induced with an effective adjuvant, polyriboinosinic:polyribocytidyl acid (poly IC) and that the combination of transient Treg-cell depletion with poly IC induced potent responses. These findings highlight the capacity for manipulating Treg cells to induce protective adaptive immunity to SARS-CoV-2 with activating antigen-presenting DCs, which may improve the efficacy of ongoing vaccine therapies and help enhance responses to emerging SARS-CoV-2 variants.


Biomaterials ◽  
2021 ◽  
pp. 121334
Author(s):  
Ruby Maharjan ◽  
Jeong Uk Choi ◽  
Seho Kweon ◽  
Rudra Pangeni ◽  
Na Kyeong Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document